Magnetic resonance imaging in coronary artery bypass surgery – improvement of global and segmental function in patients with severely compromized left ventricular function by Thielmann, Matthias et al.
Vascular Health and Risk Management 2006:2(4) 465–475
© 2006 Dove Medical Press Limited. All rights reserved
465
REVIEW
Leila Fernandes Araujo
Alexandre de Matos Soeiro
Juliano Lara Fernandes
Antônio Eduardo Pesaro
Carlos V Serrano Jr
Heart Institute (InCor), University
of São Paulo, School of Medicine,
Brazil
Correspondence: Carlos V Serrano Jr
Coronary Care Unit, Av. Dr. Enéas
Carvalho Aguiar, 44 – sala 12 – bloco 2,
São Paulo - SP - 05403-900, Brazil
Tel +55 11 3069 5058
Fax +55 11 3088 3809
Email carlos.serrano@incor.usp.br
Abstract: Despite numerous studies on women’s cardiac health throughout the past decade, the
number of female deaths caused by cardiovascular disease still rises and remains the leading cause
of death in women in most areas of the world. Novel studies have demonstrated that cardiovascular
disease, and more specifically coronary artery disease presentations in women, are different than
those in men. In addition, pathology and pathophysiology of the disease present significant
gender differences, which leads to difficulties concerning diagnosis, treatment and outcome of the
female population. The reason for this disparity is all steps for female cardiovascular disease
evaluation, treatment and prevention are not well elucidated; and an area for future research. This
review brings together the most recent studies published in the field of coronary artery disease
in women and points out new directions for future investigation on some of the important issues.
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Introduction
The first female-specific recommendations for preventive cardiology were published in
1999 (Mosca et al 1999). Even though research in the treatment of cardiovascular disease
(CVD) had advanced in many areas, it remains the leading cause of death in women in
most parts of the world. Studies have shown that 500 thousand women die of CVD every
year in the United States, somewhat near one death every minute (American Heart
Association 2003). Such index exceeds not only the number of deaths in men, but also the
next seven causes of death in women combined, and more importantly, coronary artery
disease (CAD) is believed to be the major cause responsible for these deaths (American
Heart Association 2003). Over a quarter of a million deaths per year are attributed to CAD
alone in the United States (Merz et al 2004). Although already high, these figures are
expected to rise even more during the next decades, due to an increase of diabetes and
obesity, as well as the aging of the world population (Merz et al 2004).
Even though women have a higher frequency of chest pain/angina than men, the
incidence of obstructive CAD in the female population is lower when compared with
men with similar symptoms (Kenedy et al 1982; Diamond et al 1983; Merz et al 1999). In
addition, it would appear that young women with obstructive CAD have a worse
prognosis after acute myocardial infarction (AMI), whereas older women in similar
circumstances often present with larger number of comorbidities that adversely influence
the outcome, when compared to men (Coronado et al 1997). Women with acute coronary
syndromes (ACS) are also less likely to receive rapid effective diagnosis and treatment
than are men (Ayanian and Epstein 1991; Maynard et al 1996; Pope
et al 2000).
Regarding the North American population, the Women’s Ischemic Syndrome
Evaluation (WISE) study workshop (Hayes et al 2004; Maseri 2004; Nabel et al 2004;
Pepine et al 2004; Shaw et al 2004; Waters et al 2004) from the National Heart, Lung and
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Objectives: In the present study, patients with severely compromized left ventricular function 
underwent magnetic resonance imaging (MRI) before and after coronary artery bypass grafting 
(CABG). Although improvement of global myocardial contractile function has been shown 
before, we sought to evaluate whether a functional contractile improvement may be determin-
able on a myocardial segmental basis after CABG surgery.
Methods: Thirty-three CABG patients with left ventricular ejection fraction (LVEF) 30% 
prospectively underwent MRI to compare pre- and postoperative functional data. At follow-up, 
all survivors underwent clinical assessment. In 16 patients (three patients died perioperatively, 
13 could were lost to MRI follow-up because of cardiac resynchronization therapy and other 
reasons) postoperative MRI scanning was performed.
Results: In-hospital mortality was 9%. At 20 ± 2 months after surgery, New York Heart Asso-
ciation class improved from 3.0 ± 0.1 to 2.2 ± 0.2 (p < 0.01). Left ventricular end-diastolic 
volumes decreased signiﬁ  cantly from 229 ± 14 mL to 189 ± 19 mL (p < 0.05). LV end-systolic 
volumes decreased signiﬁ  cantly from 163 ± 13 mL to 126 ± 17 mL (p < 0.05). LVEF improved 
from 30 ± 2% to 36 ± 3% (p < 0.05). On a segmental basis, 42 out of 875 segments (4.8%) 
had normal function before surgery, at follow-up, 177 segments (20.4%) had normal regional 
function (p < 0.05).
Conclusions: Patients who undergo CABG surgery with severely compromized left ventricular 
function, postoperative MRI shows improved global and segmental cardiac function at mid-term 
follow-up. At the same time there is considerable clinical improvement.
Keywords: coronary artery bypass grafting, magnetic resonance imaging, left ventricular 
function, outcomes
Introduction
A subset of patients with severe ischemic cardiomyopathy appears to beneﬁ  t from 
revascularization. However, the selection of these patients for revascularization is often 
difﬁ  cult. On the one hand, there are increased preoperative risks and co-morbidities 
in these patients, which must be weighed against the potential to improve contractile 
function, prognosis, and symptoms. This provides the rationale for noninvasive viabil-
ity testing by using magnetic resonance imaging (MRI). Besides the quantiﬁ  cation of 
myocardial scar tissue using late enhancement (Kim et al 1999; Hunold et al 2005), 
MRI has also been shown to reliably assess the extent of regional myocardial con-
traction (Selvanagayam et al 2004) as well as global volume and function parameters 
(Westenberg et al 2005).
Left ventricular (LV) function is among the most important determinants of prog-
nosis in patients with coronary artery disease (CAD) (Bonow et al 2002). In patients Vascular Health and Risk Management 2006:2(4) 465–475
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with ischemic LV dysfunction, CABG is associated with a 
signiﬁ  cant independent reduction in mortality (Veenhuyzen 
et al 2001). In the absence of myocardial viability, however, 
myocardial revascularisation is not associated with any 
signiﬁ  cant difference in outcomes, irrespective of treatment 
strategy (Allman et al 2002). In CABG patients with preop-
erative LV dysfunction, MRI hyperenhancement has been 
shown to reliably indicate myocardial scar tissue (Klein et al 
2002). Using magnetic resonance imaging, cardiac function 
can be assessed globally and regionally (Selvanagayam et al 
2004). In the present study, we pre- and postoperatively 
determined global and segmental cardiac function with car-
diac MRI. We were therefore interested whether, in addition 
to an improvement of global myocardial contractility, func-
tional improvement could also be observed on a myocardial 
segmental basis after CABG surgery.
Material and methods
Patients
Thirty-three patients with a left ventricular ejection frac-
tion 30% (as determined by coronary angiography) 
prospectively underwent MRI scanning before coronary 
artery bypass grafting (CABG). According to the protocol, 
the patients were contacted after 18 months and a second 
MRI scan was performed thereafter. Eventually, of the 33 
patients who were scanned preoperatively, 16 underwent 
postoperative MRI after a mean follow-up of 20 ± 2 months. 
All patients gave their informed consent, and the study was 
approved by the institutional ethics committee.
Magnetic resonance imaging
A 1.5 T scanner (Magnetom Sonata, Siemens Medical Solu-
tions, Erlangen, Germany) was used for all MRI examina-
tions. The MRI protocol included a functional study of the 
left ventricle using an ECG-triggered breath-hold segmented 
steady-state free precession (SSFP; TrueFISP®) cine 
sequence (TR, 3.0 ms; TE, 1.5 ms, ﬂ  ip angle, 60°) with a slice 
thickness of 8 mm. After three standard long axes (horizontal 
and vertical, long axis left ventricular outﬂ  ow tract), contigu-
ous short axis slices were acquired to cover the entire LV 
without interslice gap. After injection of 0.2 mmol/kg bw Gd-
DTPA (Magnevist™, Schering AG, Berlin, Germany), “late 
enhancement” (LE) scans were collected in three long and 
all short axis orientations using a breath-hold ECG-triggered 
2D inversion recovery TurboFLASH sequence (TR, 8 ms; 
TE, 4 ms; ﬂ  ip angle, 25°) as described elsewhere (Simonetti 
et al 2001). Images were acquired subsequently 8 to 15 
minutes after injection. The inversion time (TI, nonselective 
inversion pulse) was adjusted manually between 180 and 
300 ms to null the signal of normal myocardium. Depending 
on the ﬁ  eld of view (FOV), the typical in-plane resolution 
was 1.6 × 1.3 mm2 for all sequences. Total imaging time 
including patient positioning was 45–60 minutes.
Image analysis, scoring, and calculating
All MRI examinations were interpreted by two radiologists 
experienced in cardiac MRI by consensus. TrueFISP images 
were reviewed as cine-loops on a workstation, whereas hard-
copies were used for the read-out of the inversion recovery 
TurboFLASH images. All inversion recovery TurboFLASH 
data sets in long and short axis orientation were reviewed 
regarding LE.
Concerning segmental function, standardized myocardial 
segmentation and nomenclature for tomographic imaging 
of the heart has been suggested by the American Heart 
Association. A 17 segment model of the left ventricle was 
established as well as an assignment of left ventricular myo-
cardial segments to coronary arterial topography (Cerqueira 
et al 2002). In basal and mid-ventricular portions of the LV, 
the myocardial circumference was additionally divided into 
6 subsegments; in the apical third of the LV, four segments 
were evaluated plus the apex itself. This resulted in 49 to 61 
segments per patient depending on LV dimensions: Accord-
ing to the AHA statement, a mean score was then calculated 
to assign the scores from all designated short axis images to 
the individual 17 AHA segments.
The 17 segments were distributed into 3 vessel territo-
ries, belonging to the 3 large epicardial arteries left anterior 
descending (LAD, 7 segments), circumﬂ  ex artery (Cx, 5 
segments) and right coronary artery (RCA, 5 segments). All 
17 segments in each patient were assigned one of the major 
large epicardial arteries. A mean late enhancement score 
for each of these vessel territories was calculated. Based 
on the published data by Kim et al (2000), dysfunctional 
segments with LE score 1 or 2 are expected to recover after 
sufﬁ  cient revascularization; those segments scored 3 or 4 
are considered unlikely to improve function after restitution 
of perfusion.
A score 1 to 4 system was used to describe the transmural 
extent of LE in each of the turboFLASH short axis images: 
Score 1 = no LE; score 2 = subendocardial LE including 
less than 50% of the wall thickness; score 3 = nontrans-
mural LE including 50% or more of the wall thickness; 
score 4 = transmural LE (Hunold et al 2002). The extent of 
segmental wall thickening (ie, the degree of wall motion or 
contractility) of the left ventricle was graded on a ﬁ  ve-point Vascular Health and Risk Management 2006:2(4) 465–475
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MRI in coronary artery bypass surgery
scale in which a score of 0 indicated normal function, a score 
of 1 mild or moderate hypokinesia, a score of 2 severe hypo-
kinesia, a score of 3 akinesia and a score of 4 dyskinesia (Kim 
et al 2000). Global LV function was assessed by slice sum-
mation in end diastole and end systole of the short axis slices 
after manual planimetry of the endocardial borders using the 
ARGUS® software (Siemens AG, Munich, Germany).
Surgical management
Surgical revascularization was performed as previously 
described (Thielmann et al 2006) in all patients using median 
sternotomy, standard CPB technique with ascending aortic 
and two-stage venous cannulation. During CPB, moderate 
hemodilution (hematocrit 20%–25%) with mild systemic 
hypothermia (>32 °C) was maintained. Myocardial protec-
tion was achieved using antegrade and optional retrograde 
cold crystalloid (Bretschneider) cardioplegic arrest and 
additional topical cooling. Patients were postoperatively 
monitored with respect to arterial pressure, pulmonary pres-
sure, and central venous pressure.
Clinical follow-up
Patients were contacted 18 months after surgery. The clinical 
status was assessed using a simple questionnaire.
Statistical analysis
Results are expressed as mean ± SEM. For parametric data, 
differences of means between groups were evaluated using 
Student’s t-test. For categorical data, Fischer’s excact test 
was applied. Differences were considered to be signiﬁ  cant 
with a P value < 0.05. A possible correlation between 
intraoperative graft ﬂ  ow and change in myocardial func-
tion from before surgery to after surgery was investigated 
using a bivariate correlation analysis (SPSS 13.0, SPSS Inc., 
Chicago, Il, USA).
Results
Three patients died perioperatively (hospital mortality 9%), 
during follow-up one patient died from stroke. Out of the 
remaining 29 patients, six patients had a contraindication 
to undergo MRI at the time of follow up because they had 
received cardiac resynchronization therapy using implant-
able pacemakers and deﬁ  brillators in the meantime. Three 
patients did not want to undergo MRI again, because they 
had experienced considerable claustrophobia at the time of 
the preoperative scan. In three patients, mobility was severely 
compromized for noncardiac reasons and one patient had 
moved abroad and was not available for MRI.
Tables 1 and 2 show pre-, intra- and postoperative data 
of the remaining 16 patients. One patient had one vessel 
disease, one had two vessel disease, all others had three ves-
sel disease. Volume (end systolic and end diastolic volume) 
and function (left ventricular ejection fraction) parameters, 
as determined by MRI, signiﬁ  cantly improved from before 
to after surgery (Figures 1 and 2). As an example, Figure 3 
shows pre- and postoperative MRI scans. In the respective 
patient, left ventricular function improved considerably 
(Figure 3).
In parallel to global functional improvement, there was 
functional improvement on a segmental basis. Before sur-
gery, 417 out of 875 segments (48%) in 16 patients showed 
evidence of late enhancement. 42 segments (4.8%) were 
classiﬁ  ed to be normokinetic (functional score = 0). After sur-
gery, 177 segments (20.4%) were normokinetic (p  0.05). 
Of 388 segments preoperatively classiﬁ  ed to be severely 
hypokinetic (functional score = 2), 141 (36.3%) improved 
by at least one score point. Of 193 segments classiﬁ  ed as 
akinetic before surgery (functional score = 3), 21 segments 
(10.8%) improved by at least one score point at the time of 
follow-up.
Myocardial segments assigned to the LAD territory had a 
mean score of 3.2 ± 0.1 before surgery and a score of 2.8 ± 0.2 
at follow up (p  0.05). Myocardial segments assigned to the 
circumﬂ  ex artery had a mean functional score of 3.2 ± 0.2 
before and 2.9 ± 0.2 after surgery (p = 0.1). Left ventricular 
myocardial segments assigned to the right coronary artery 
territory had a mean score of 2.6 ± 0.2 before and 2.4 ± 0.3 
after surgery (p = 0.10).
There was also signiﬁ  cant clinical improvement. Before 
surgery patients reported a mean NYHA class of 3.0 ± 
0.1. Eighteen months after surgery mean NYHA class was 
2.2 ± 0.2 (p  0.01).
Table 1 Preoperative patient data
Age [Years]  61 ± 3
Female[n] 0  (0)
Hypertension [n]  10 (63)
Hyperlipidemia [n]  11 (69)
Peripheral vascular disease [n]  1 (7)
Atrial ﬁ  brillation [%]  1 (7)
Forced expiratory volume [%]  76 ± 3
Serum creatinine [mg/dL]  1.2 ± 0.0
COPD [n]  5 (31)
Re-operation [n]  1 (7)
Angiographic LVEF preop [%]  26 ± 1
MRI LVEF preop [%]  30 ± 2
Note: Means ± SEM, or number (%).
Abbreviations: COPD, Chronic obstructive pulmonary disease; LVEF, Left 
ventricular ejection fraction.Vascular Health and Risk Management 2006:2(4) 465–475
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Figure 1 Volume parameters obtained by using magnetic resonance imaging before (crosshatched bars) and after CABG (hatched bars). Data are mean ± SEM. ESV, Endsys-
tolic volume; EDV, Enddiastolic volume. Numerical values above error bars indicate level of statistical signiﬁ  cance between the groups (Student’s t-test for unpaired samples).
Conclusion
In patients with signiﬁ  cant coronary artery disease and left 
ventricular dysfunction, survival after coronary artery bypass 
grafting has been shown to be better than with medical 
therapy alone (Lytle et al 2003). However, only those patients 
beneﬁ  t from surgical revascularisation who displays the 
presence of dysfunctional but viable myocardium. Patients 
without viable myocardium do not beneﬁ  t from myocardial 
revascularisation, irrespective of treatment strategy (Allman 
et al 2002). The present study shows favorable results at 
20 months follow-up after surgical revascularization. Reverse 
remodelling of the dysfunctional left ventricle could be 
demonstrated by an improvement of global and segmental 
function and patients were in a lower NYHA class.
The transmural extent of hyperenhancement was reported 
to signiﬁ  cantly relate to the likelihood of improvement in 
contractility after revascularization in a reversed way (Kim 
et al 2000). Contractility improved in 78% of segments with 
no hyperenhancement but in only 1 of 58 segments with 
hyperenhancement of more than 75%. Myocardium that 
shows transmural late enhancement, which represents scare 
tissue, is not believed to be improved by revascularisation 
(Kim et al 1999, 2000).
The postoperative dropout concerning magnetic reso-
nance follow up scan was considerable because of many 
reasons (see Results section), so that only 16 of 29 surviving 
patients could be investigated. Postoperative implantation of 
deﬁ  brillators and pacemakers has been described to lead to 
a loss of follow up in patients due to undergo postoperative 
MRI (Kim et al 2000). In recent years, cardiac resynchro-
nization therapy has further increased the indication for 
pacemaker/deﬁ  brillator implantation in patients with com-
promized left ventricular function.
In conclusion, the present study clearly conﬁ  rms the 
results of several recent clinical trials that noninvasive 
myocardial viability testing with magnetic resonance imag-
ing detect those patients with severely compromized left 
Table 2 Intra- and postoperative patient data
CPB time [min]  106 ± 7
Aortic cross clamp time [min]  67 ± 4
Distal bypass anastomoses [n]  3.7 ± 0.3
Proximal anastomoses [n]  1.9 ± 0.2
Maximum postoperative cTnI [ng/ml]  9.8 ± 3.8
Maximum postoperative myoglobin [ng/ml]  645 ± 210
Ventilation time [h]  11 ± 2
Stay on ICU [h]  70 ± 41
MRI EF postop [%]  36 ± 3
Note: Means ± SEM, or number (%).
Abbreviations: LVEF, Left ventricular ejection fraction; CPB, Cardiopulmonary 
bypass; cTnI, cardiac troponin I; ICU, Intensive care unit.Vascular Health and Risk Management 2006:2(4) 465–475
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Abstract: Despite numerous studies on women’s cardiac health throughout the past decade, the
number of female deaths caused by cardiovascular disease still rises and remains the leading cause
of death in women in most areas of the world. Novel studies have demonstrated that cardiovascular
disease, and more specifically coronary artery disease presentations in women, are different than
those in men. In addition, pathology and pathophysiology of the disease present significant
gender differences, which leads to difficulties concerning diagnosis, treatment and outcome of the
female population. The reason for this disparity is all steps for female cardiovascular disease
evaluation, treatment and prevention are not well elucidated; and an area for future research. This
review brings together the most recent studies published in the field of coronary artery disease
in women and points out new directions for future investigation on some of the important issues.
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Introduction
The first female-specific recommendations for preventive cardiology were published in
1999 (Mosca et al 1999). Even though research in the treatment of cardiovascular disease
(CVD) had advanced in many areas, it remains the leading cause of death in women in
most parts of the world. Studies have shown that 500 thousand women die of CVD every
year in the United States, somewhat near one death every minute (American Heart
Association 2003). Such index exceeds not only the number of deaths in men, but also the
next seven causes of death in women combined, and more importantly, coronary artery
disease (CAD) is believed to be the major cause responsible for these deaths (American
Heart Association 2003). Over a quarter of a million deaths per year are attributed to CAD
alone in the United States (Merz et al 2004). Although already high, these figures are
expected to rise even more during the next decades, due to an increase of diabetes and
obesity, as well as the aging of the world population (Merz et al 2004).
Even though women have a higher frequency of chest pain/angina than men, the
incidence of obstructive CAD in the female population is lower when compared with
men with similar symptoms (Kenedy et al 1982; Diamond et al 1983; Merz et al 1999). In
addition, it would appear that young women with obstructive CAD have a worse
prognosis after acute myocardial infarction (AMI), whereas older women in similar
circumstances often present with larger number of comorbidities that adversely influence
the outcome, when compared to men (Coronado et al 1997). Women with acute coronary
syndromes (ACS) are also less likely to receive rapid effective diagnosis and treatment
than are men (Ayanian and Epstein 1991; Maynard et al 1996; Pope
et al 2000).
Regarding the North American population, the Women’s Ischemic Syndrome
Evaluation (WISE) study workshop (Hayes et al 2004; Maseri 2004; Nabel et al 2004;
Pepine et al 2004; Shaw et al 2004; Waters et al 2004) from the National Heart, Lung and
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MRI in coronary artery bypass surgery
Figure 3 MR Imaging of a 64 year old male before (top line) and after (bottom line) 3-fold CABG. SSFP Cine images in enddiastole (A) and endsystole (B) reveal the 
severely impaired global LV function before surgery (EF 30%) with akinesia in the apical inferoseptal and anterolateral wall and the apex (segments 14, 16, and 17) and 
hypokinesie in the basal and mid-ventricular lateral wall. The contrast-enhanced TurboFLASH image (C) shows broad subendocardial late enhancement (bright signal) in the 
apical septum, thin LE in the lateral wall and transmural LE in the apex meaning chronic scar. LV function after surgery (D, E) shows no improvement in the apical septum 
and the apex, whereas the complete lateral wall improved and became normokinetic. No changes in scar extent (F). Global LV function improved to EF 40%, LV volumes 
decreased.
before CABG after CABG
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Figure 2 Left ventricular ejection fraction (LVEF) obtained by using magnetic resonance imaging before and after surgery. Data are mean ± SEM. Numerical value above 
error bar indicates level of statistical signiﬁ  cance between groups (Student’s t-test for unpaired samples).Vascular Health and Risk Management 2006:2(4) 465–475
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Thielmann et al
ventricular function, in whom CABG surgery can signiﬁ  -
cantly improve global left ventricular function (Allman et al 
2002; Bax et al 1997). Moreover, the present study could also 
demonstrate a signiﬁ  cant reverse remodelling and improve-
ment of left ventricular function after CABG surgery on 
a myocardial segmental basis using MRI viability testing. 
After surgery, left ventricular function improves along with 
a considerable clinical beneﬁ  t of the patients.
Limitations
Our study encompasses the experience at a single tertiary 
medical center; therefore, the generalizability of our ﬁ  nd-
ings may not extend to all of the clinical centers performing 
CABG. One of the main limitations of the present study is the 
high drop-out rate during the follow-up period. Only 16 out 
of 29 surviving patients were eligible for postoperative MRI 
follow-up because of several limitations and contraindica-
tions to undergo MRI scan, having received cardiac resyn-
chronization therapy in the meantime, had claustrophobia, 
were unavailable or had a severely compromized mobility 
for noncardiac reasons.
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